SCHEMBL5202819

SCHEMBL5202819

CC1=CCC(C)C2(CCCC(C)(C)C2=O)C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21001032 0.78 LIG1 (0.32) LIG1
SCHEMBL24475286 0.76 CYP3A4 (0.33) LIG1
SCHEMBL5200872 0.76 CYP3A4 (0.33) LIG1
SCHEMBL5200877 0.74 LIG1 (0.32) LIG1
SCHEMBL5200075 0.70 LIG1 (0.31) LIG1
SCHEMBL22614840 0.70 LIG1 (0.31) LIG1
SCHEMBL30879573 0.70 LIG1 (0.31) LIG1
SCHEMBL5200793 0.69 LIG1 (0.32) LIG1
SCHEMBL21001389 0.66 LIG1 (0.33) LIG1
SCHEMBL4435768 0.66 TSHR (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411110-B1 Spiro compounds as perfuming ingredients FIRMENICH & CIE (CH) 2007-08-22 EP disclosed
US-7256170-B2 Spiro compounds as perfuming ingredients FIRMENICH SA (CH) 2007-08-14 US disclosed
EP-1411110-A1 Spiro compounds as perfuming ingredients FIRMENICH SA (CH) 2004-04-21 EP disclosed
US-20040072721-A1 Spiro compounds as perfuming ingredients FIRMENICH SA (CH) 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072721-A1 Spiro compounds as perfuming ingredients SORD, PIR, AKR1C4 LIG1 3962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.